SL
Svetlana Lucas
DELAYED 1 MONTH
Chief Business Officer; Director
aTYR PHARMA INC
Scribe Therapeutics, Inc.
Filings
2
Companies
2
Latest
May 11, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
69
SCTXCLUSTER 2
Scribe Therapeutics, Inc.
Svetlana Lucas
Chief Business Officer
Purchase
$45.0K
3,000 sh
Jul 28 1:42 AM
Jul 23, 2026